Buick R N, Pullano R, Trent J M
Cancer Res. 1985 Aug;45(8):3668-76.
We describe the derivation of three human ovarian carcinoma cell lines and the comparison of their properties with two previously described cell lines of like histology (SKOV-3 and CAOV-3). Two of the new lines (HOC-1 and HOC-7) were derived from separate ascites tumors (at 9-month intervals) of a patient with well-differentiated serous adenocarcinoma of the ovary. The third new line, HEY, was derived from a human ovarian cancer xenograft (HX-62) originally grown from a peritoneal deposit of a patient with moderately differentiated papillary cystadenocarcinoma of the ovary. The cell lines demonstrated differential ability to grow in semisolid culture and as xenografts in immunologically deprived CBA/CJ mice. Dose-response curves were generated for clonogenic cell survival of cells exposed to common chemotherapeutic agents; one of the lines (HEY) shows a degree of resistance to the alkylating agent cis-diamminedichloroplatinum(II) (cis-platinum). Common karyological features included structural abnormalities of chromosomes 3 and 11. Heterogeneity of expression of ovarian tumor-associated antigens was documented.
我们描述了三种人卵巢癌细胞系的衍生过程,并将它们的特性与之前描述的两种组织学相似的细胞系(SKOV-3和CAOV-3)进行了比较。其中两个新细胞系(HOC-1和HOC-7)源自一名卵巢高分化浆液性腺癌患者的不同腹水肿瘤(间隔9个月)。第三个新细胞系HEY源自一个人卵巢癌异种移植瘤(HX-62),该异种移植瘤最初由一名卵巢中分化乳头状囊腺癌患者的腹膜沉积物生长而来。这些细胞系在半固体培养中以及作为免疫缺陷CBA/CJ小鼠体内的异种移植瘤生长时,表现出不同的生长能力。针对暴露于常用化疗药物的细胞克隆形成存活情况生成了剂量反应曲线;其中一个细胞系(HEY)对烷化剂顺二氨二氯铂(II)(顺铂)表现出一定程度的抗性。常见的核型特征包括3号和11号染色体的结构异常。记录了卵巢肿瘤相关抗原表达的异质性。